Medical Devices Canada

Canada At-Home Diagnostic Tests Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Canada At-Home Diagnostic Tests Market Industry Trends and Forecast to 2034: Segmented by (Test, Format, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Canada · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $711.7 Mn Placeholder estimate
Estimate 2025 $760.9 Mn 8.9% of the global market
Projected 2034 $1.39 Bn 82.3% Adds $626.2 Mn over 9 forecast years
CAGR 2025–2034 6.9% Faster than 28% of 173 Medical Devices markets here
Key players 6 +1
  • Canada is 8.86% of the global market.
  • In North America, the largest is US at $3.99 Bn.
  • Fastest growing: Canada (this report) at 6.9% a year.
  • Canada ranks 2nd of 2 by size in North America.

Market size projection

Canada

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$626.2 Mn total, 2026–2034

Year-by-year market size, 2024–2034
At-Home Diagnostic Tests Market market size by year, Canada
YearMarket sizeChange that yearSince 2025
2024 (estimate) $711.7 Mn — —
2025 (base) $760.9 Mn +$49.1 Mn —
2026 (forecast) $813.3 Mn +$52.5 Mn +6.9%
2027 (forecast) $869.5 Mn +$56.1 Mn +14.3%
2028 (forecast) $929.5 Mn +$60.0 Mn +22.2%
2029 (forecast) $993.6 Mn +$64.1 Mn +30.6%
2030 (forecast) $1.06 Bn +$68.6 Mn +39.6%
2031 (forecast) $1.14 Bn +$73.3 Mn +49.2%
2032 (forecast) $1.21 Bn +$78.3 Mn +59.5%
2033 (forecast) $1.30 Bn +$83.8 Mn +70.5%
2034 (forecast) $1.39 Bn +$89.5 Mn +82.3%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Canada At-Home Diagnostic Tests Market Analysis at a glance
Market size, 2025$760.9 Mn placeholder estimate
Forecast, 2034$1.39 Bn placeholder estimate
Growth (CAGR), 2025–20346.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
Also calledHome Diagnostics
SegmentsTest and format (see all)
Key playersAbbott Laboratories, Roche Diagnostics, Everlywell, LetsGetChecked, Cue Health and 1 more (see all)
Regulator in CanadaHealth CanadaSource: Health Canada. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Canada At-Home Diagnostic Tests Market Analysis Executive Summary

At-home diagnostic tests let people check health conditions such as infections, hormones and cholesterol themselves, with results on a strip or an app.

Key segments of the at-Home Diagnostic Tests market include test (Infectious Disease, Pregnancy and Fertility and Glucose and Cholesterol) and format (Lateral Flow, Sample Collection Kits and Digital Readers).

Bar chart: Canada At-Home Diagnostic Tests market size, 2024–2034, placeholder estimates. $711.7 Mn in 2024, $760.9 Mn in 2025 and $1.39 Bn in 2034, 6.9% CAGR.
Canada At-Home Diagnostic Tests market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Canada At-Home Diagnostic Tests Market Dynamics

Market Growth Drivers

Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the at-Home Diagnostic Tests market.

Opportunity

Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the at-Home Diagnostic Tests market room to grow, especially in emerging markets.

Market Restraints

Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the at-Home Diagnostic Tests market.

Competitive Landscape for At-Home Diagnostic Tests Market in Canada

The at-Home Diagnostic Tests market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for At-Home Diagnostic Tests Market in Canada

At-Home Diagnostic Tests in Canada: rules and payment

Health Canada licenses Class II, III and IV medical devices; Class I devices are sold by companies that hold an establishment licence.⁠[1] Each province and territory runs public health insurance under the Canada Health Act, which covers medically necessary hospital and doctor services.⁠[2]

[1] Health Canada. Checked 14 Nov 2026.

[2] Health Canada. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how at-Home Diagnostic Tests products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Canada.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in At-Home Diagnostic Tests right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

At-Home Diagnostic Tests in context

Canada compared

  • Health spending per person: 6,378 US$ per person (2024). World: 1,317 US$ per person (2023).[1]
  • Doctors: 2.82 per 1,000 people (2023). World: 1.86 per 1,000 people (2022).[2]
  • People aged 65 and over: 20.3% of people (2025). World: 10.4% of people (2025).[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the At-Home Diagnostic Tests market in Canada?
Placeholder estimate: about $760.9 Mn in 2025, rising to about $1.39 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the At-Home Diagnostic Tests market in Canada growing?
Placeholder estimate: about 6.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the At-Home Diagnostic Tests market report cover?
The report splits the market by test (Infectious Disease, Pregnancy and Fertility, Glucose and Cholesterol, Colorectal Screening and more) and format (Lateral Flow, Sample Collection Kits, Digital Readers).
Who are the key players in the At-Home Diagnostic Tests market?
Key players include Abbott Laboratories, Roche Diagnostics, Everlywell, LetsGetChecked, Cue Health and iHealth Labs.
What is driving the At-Home Diagnostic Tests market?
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the at-Home Diagnostic Tests market.
Who regulates At-Home Diagnostic Tests in Canada?
Health Canada licenses Class II, III and IV medical devices; Class I devices are sold by companies that hold an establishment licence. Source: Health Canada. Checked 14 Nov 2026.
How is healthcare paid for in Canada?
Each province and territory runs public health insurance under the Canada Health Act, which covers medically necessary hospital and doctor services. Source: Health Canada. Checked 14 Nov 2026.
How much research is published on At-Home Diagnostic Tests?
PubMed lists 9,816 papers on At-Home Diagnostic Tests added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Canada

See all

Related on diagnostics and lab testing

See the topic